- Home
- BNR vs IZM Comparison
BNR vs IZM Comparison
Compare BNR & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- IZM
- Stock Information
- Founded
- BNR 2014
- IZM 2011
- Country
- BNR China
- IZM China
- Employees
- BNR N/A
- IZM N/A
- Industry
- BNR Medical Specialities
- IZM Consumer Electronics/Video Chains
- Sector
- BNR Health Care
- IZM Consumer Discretionary
- Exchange
- BNR Nasdaq
- IZM Nasdaq
- Market Cap
- BNR 38.3M
- IZM 31.8M
- IPO Year
- BNR 2020
- IZM 2023
- Fundamental
- Price
- BNR $4.60
- IZM $2.53
- Analyst Decision
- BNR
- IZM
- Analyst Count
- BNR 0
- IZM 0
- Target Price
- BNR N/A
- IZM N/A
- AVG Volume (30 Days)
- BNR 19.9K
- IZM 31.5K
- Earning Date
- BNR 08-21-2025
- IZM 07-25-2025
- Dividend Yield
- BNR N/A
- IZM N/A
- EPS Growth
- BNR N/A
- IZM N/A
- EPS
- BNR N/A
- IZM N/A
- Revenue
- BNR $72,112,038.00
- IZM $180,553,977.00
- Revenue This Year
- BNR $136.32
- IZM N/A
- Revenue Next Year
- BNR N/A
- IZM N/A
- P/E Ratio
- BNR N/A
- IZM N/A
- Revenue Growth
- BNR 0.53
- IZM N/A
- 52 Week Low
- BNR $2.18
- IZM $1.18
- 52 Week High
- BNR $7.90
- IZM $3.19
- Technical
- Relative Strength Index (RSI)
- BNR 68.63
- IZM 50.99
- Support Level
- BNR $3.06
- IZM $2.50
- Resistance Level
- BNR $4.96
- IZM $2.65
- Average True Range (ATR)
- BNR 0.27
- IZM 0.10
- MACD
- BNR 0.13
- IZM -0.02
- Stochastic Oscillator
- BNR 81.05
- IZM 21.43
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.